牛牛AI助理已提取核心訊息
Cardio Diagnostics Holdings, Inc. has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an equity offering with the first sale dated 02/02/2024. The biotechnology company, incorporated in Delaware within the last five years, is headquartered in Chicago, Illinois. Key executives and directors, including Meeshanthini Dogan, Warren Hosseinionn, Oded Levy, Robert Philibert, Elisa Luqman, Stanley Lau, Paul Burton, and James Intrater, are listed in the filing. Cardio Diagnostics Holdings has opted not to disclose its revenue range or aggregate net asset value. The offering, which does not exceed one year, involves common stock and warrants to purchase common stock, with a minimum investment of $50,000 from outside investors. The total offering and amount...Show More
Cardio Diagnostics Holdings, Inc. has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an equity offering with the first sale dated 02/02/2024. The biotechnology company, incorporated in Delaware within the last five years, is headquartered in Chicago, Illinois. Key executives and directors, including Meeshanthini Dogan, Warren Hosseinionn, Oded Levy, Robert Philibert, Elisa Luqman, Stanley Lau, Paul Burton, and James Intrater, are listed in the filing. Cardio Diagnostics Holdings has opted not to disclose its revenue range or aggregate net asset value. The offering, which does not exceed one year, involves common stock and warrants to purchase common stock, with a minimum investment of $50,000 from outside investors. The total offering and amount sold are both listed as $1,000,000 USD, with no remaining to be sold. Sales commissions are estimated at $100,000 USD, with no finder's fees. The offering is not made in connection with a business combination transaction, and the proceeds are not intended for payments to the named executives, directors, or promoters. The company has claimed an exemption under Rule 506(b) and has completed the offering with seven investors.
Cardio Diagnostics Holdings, Inc.已向美國證券交易委員會提交了D表證券豁免發行通知，表明了新的股票發行通知，首次出售日期爲2024年2月2日。這家生物技術公司在過去五年內在特拉華州註冊成立，總部位於伊利諾伊州芝加哥。文件中列出了包括Meeshanthini Dogan、Warren Hosseinonn、Oded Levy、Robert Philibert、Elisa Luqman、Stanley Luqman、Stanley、Paul Burton和James Intrater在內的主要高管和董事。Cardio Diagnostics Holdings選擇不透...展開全部
Cardio Diagnostics Holdings, Inc.已向美國證券交易委員會提交了D表證券豁免發行通知，表明了新的股票發行通知，首次出售日期爲2024年2月2日。這家生物技術公司在過去五年內在特拉華州註冊成立，總部位於伊利諾伊州芝加哥。文件中列出了包括Meeshanthini Dogan、Warren Hosseinonn、Oded Levy、Robert Philibert、Elisa Luqman、Stanley Luqman、Stanley、Paul Burton和James Intrater在內的主要高管和董事。Cardio Diagnostics Holdings選擇不透露其收入範圍或總淨資產價值。此次發行不超過一年，涉及普通股和購買普通股的認股權證，外部投資者的最低投資額爲50,000美元。總髮行量和銷售金額均列爲1,000,000美元，沒有剩餘的待售商品。銷售佣金估計爲100,000美元，不收取任何發現費。此次發行與企業合併交易無關，所得款項不用於向指定高管、董事或發起人付款。該公司已根據第506（b）條申請豁免，並已與七名投資者一起完成了此次發行。
有用
沒用